---
$id: https://graph.org.ai/products/commodity/51183902
$type: Product
source: UNSPSC
code: "51183902"
title: "Ragaglitazar"
class: "51183900"
classTitle: "Antidiabetic and hyperglycemic peroxisome proliferator-activated receptors"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ragaglitazar

**UNSPSC Code**: 51183902
**Class**: [Antidiabetic and hyperglycemic peroxisome proliferator-activated receptors](Antidiabetic and hyperglycemic peroxisome proliferator-activated receptors.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-diabetic agent with the molecular formula C25H25NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) Q5ELR5A7Y5, chemically known as benzenepropanoic acid, alpha-ethoxy-4-(2-(10h-phenoxazin-10-yl)ethoxy)-, (alphas)- but more generally known as ragaglitazar, which bears US NIH Compound Identifier 128814. The term RAGAGLITAZAR is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 16., No. 1.2002, List 47). Most nations, for tariff and trade purposes, schedule ragaglitazar under HS 29349990 and SITC 51579. As of Q4 2014, RAGAGLITAZAR remains US FDA's Preferred Term for this commodity. Ragaglitazar bears US NLM identifiers UMLS ID C1175029 and NCI Concept Code C75192. SMILES: CCOC(CC1=CC=C(C=C1)OCCN2C3=CC=CC=C3OC4=CC=CC=C42)C(=O)O.

